Nextgen Cancer Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 27-12-2024
- Paid Up Capital ₹ 0.10 M
as on 27-12-2024
- Company Age 8 Year, 13 Days
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2020)
- Profit -4.90%
(FY 2020)
- Ebitda -17.68%
(FY 2020)
- Net Worth -33.34%
(FY 2020)
- Total Assets -3.67%
(FY 2020)
About Nextgen Cancer Solutions
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Venkata Lingareddy and Anuradha Acharya serve as directors at the Company.
- CIN/LLPIN
U74999TG2017PTC113900
- Company No.
113900
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jan 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nextgen Cancer Solutions?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Lingareddy  | Director | 05-Jan-2017 | Current |
| Anuradha Acharya | Director | 05-Jan-2017 | Current |
Financial Performance of Nextgen Cancer Solutions.
Nextgen Cancer Solutions Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 4.9% decrease in profit. The company's net worth observed a substantial decline by a decrease of 33.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nextgen Cancer Solutions?
Unlock access to Nextgen Cancer Solutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Mapmygenome India LimitedActive 12 years 11 monthsVenkata Lingareddy and Anuradha Acharya are mutual person
Coramandel Mining & Exports Private LimitedActive 16 years 11 monthsVenkata Lingareddy is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nextgen Cancer Solutions?
Unlock and access historical data on people associated with Nextgen Cancer Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nextgen Cancer Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nextgen Cancer Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
